
Mesa Laboratories, Inc.
- Jurisdiction
United States - LEI
549300ZCG738WLX8ZW79 - ISIN
US59064R1095 (MLAB )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
7
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. Read full profile
Stock price
Fundamentals
- Net revenue
€207.94M - Gross margin
60.3% - EBIT
€11.86M - EBIT margin
5.7% - Net income
-€531.96K - Net margin
-0.3%
Statement period: - (published )
Estimates
Fiscal Year | Net revenue | Net income |
---|---|---|
|
| |
|
| |
|
|
Dividends
- Last dividend amount
-
$0.16 - Ex date
-
- Payment date
-
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
Peter Brown |
|
|
|
Buy |